Denali Therapeutics (4DN.F) Q1 2025 Earnings

27FebConfirmed
Q2 2024
Q3 2024
Q4 2024
Q1 2025
-0.77
-0.69
-0.62
-0.55

Details

Expected EPS
-0.768121272
Actual EPS
-0.6442720000000001
Surprise EPS
0.12
Surprise Percent
+16.12%

Description

Denali Therapeutics (4DN.F) has reported earnings of -0.6442720000000001 per share for Q1 2025.

0 Comments

Share your thoughts